Two New Haven-based bioscience firms have announced an agreement to collaborate on research and development of therapies for central nervous system disorders (CNS). Bexorg Inc., a techbio company ...

Background Over the last few years, there has been increasing attention to the involvement of the central nervous system in Duchenne muscular dystrophy (DMD). The aim of this study was to assess the ...